MK2461

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK2461, covering 2015-03-27 to 2015-03-27. Get the full timeline:

Most recent: Clinical Trial Update: MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) [Phase 1]